3 Item 1A. Risk Factors 15 Item 1B. Unresolved Staff Comments 48 Item 1C. Cybersecurity 48 Item 2. Properties 48 Item 3. Legal Proceedings 49 Item 4. Mine Safety Disclosures 49 PART II Item 5. Market For Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 50 Item 6. Reserved 51 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 52 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 63 Item 8. F...
Q2 FY2026 — expected 2026-09-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076730 | EDGAR | 78K words |
| 2025-02-27 | 2024-12-31 | 0000950170-25-029137 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0000950170-24-023150 | EDGAR | — |
| 2023-03-01 | 2022-12-31 | 0000950170-23-005585 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001193125-22-061686 | EDGAR | — |
| 2021-03-16 | 2020-12-31 | 0001193125-21-082849 | EDGAR | — |
| 2020-03-09 | 2019-12-31 | 0001193125-20-067198 | EDGAR | — |
| 2019-03-18 | 2018-12-31 | 0001193125-19-078332 | EDGAR | — |
| 2018-03-14 | 2017-12-31 | 0001558370-18-002068 | EDGAR | — |
| 2017-03-28 | 2016-12-31 | 0001047469-17-002096 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001193125-25-269697 | EDGAR | 25K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-105048 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066962 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125431 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0000950170-24-094009 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-057050 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062056 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0000950170-23-040670 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0000950170-23-020627 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0000950170-22-023947 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000950170-22-016142 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001193125-22-146366 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-26 | 0001193125-26-076595 | EDGAR | 8K words |
| 2026-02-23 | 0001193125-26-064270 | EDGAR | — |
| 2025-12-29 | 0001193125-25-335425 | EDGAR | — |
| 2025-11-06 | 0001193125-25-269654 | EDGAR | — |
| 2025-09-25 | 0001193125-25-217810 | EDGAR | — |
| 2025-08-07 | 0000950170-25-105032 | EDGAR | — |
| 2025-06-24 | 0001193125-25-145767 | EDGAR | — |
| 2025-05-08 | 0000950170-25-066930 | EDGAR | — |
| 2025-03-27 | 0001193125-25-065638 | EDGAR | — |
| 2025-02-27 | 0000950170-25-029021 | EDGAR | — |
175 total filings indexed. 143 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001661181 |
| Ticker | ORGO |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.organogenesis.com |
| Listed | 2016-11-29 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report